Veinplicity for Improved Venous Access: The VIVA Trial

Inclusion Criteria: * Subject is ≥ 22 years old. * Subject is assessed as having fair or poor vein quality. * Subject's both arms are suitable for cannulation. * Subject will not suffer harm from a delay in having an IV established as determined by the treating clinician. Exclusion Criteria: * Subject has existing intravenous access. * Subject has a planned or existing intra-arterial access. * Subject has broken, infected or irritated skin and/or dermatological conditions, e.g., eczema, psoriasis and/or allergic reactions, on either forearm. * Subject has an active implantable medical device. * Subject wears a transdermal drug delivery patch on her/his forearm. * Subject has an active/suspected deep vein thrombosis or thrombophlebitis, impaired circulation, impaired sensation, active/uncontrolled bleeding, recently radiated tissue, recent fracture, recent injury or surgery resulting in blood loss \> 100 mL, osteoporosis, localized abscess, localized tuberculosis, and/or a chronic wound with potential underlying osteomyelitis. * Subject has impaired cognition or communication (unable to provide accurate feedback). * Subject has a history of seizures and/or epilepsy, and/or a recent seizure, possible recent seizure or a history of possible seizures. * Subject is pregnant and/or breastfeeding at the time of study enrollment. * Subject has, at the site of or in between Veinplicity electrode application sites, an active/suspected malignancy.